homeostasis/metabolism
• FGF21-treated mice fail to exhibit a decrease in glucose serum levels unlike wild-type mice
|
• FGF21-treated mice fail to exhibit a decrease in insulin serum levels unlike wild-type mice
|
• in untreated mice
|
• FGF21-treated mice fail to exhibit a decrease in leptin serum levels unlike wild-type mice
|
• FGF21-treated mice fail to exhibit an increase in beta-hydroxybutyrate serum levels unlike wild-type mice
|
• FGF21-treated mice fail to exhibit a decrease in cholesterol serum levels unlike wild-type mice
|
• in untreated mice
|
• FGF21-treated mice fail to exhibit an increase in caloric expenditure unlike wild-type mice
• however, untreated mice exhibit normal energy homeostasis
|
• FGF21-treated mice fail to exhibit an increase in adiponectin serum levels unlike wild-type mice
|
growth/size/body
• FGF21-treated mice exhibit reduced fat mass loss compared with wild-type mice
|
• with reduced fat loss following treatment with FGF21
|
adipose tissue
• FGF21-treated mice exhibit reduced fat mass loss compared with wild-type mice
|